Sharon Barbari - Jan 1, 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, attorney-in-fact for Sharon Barbari
Stock symbol
VYNE
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:09 PM
Previous filing
Dec 15, 2023
Next filing
Aug 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYNE Stock Option (right to buy) Award $0 +20K $0.00 20K Jan 1, 2024 Common Stock 20K $2.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.